Sign in

CIK 0001395937 · Large accelerated filer

Syndax Pharmaceuticals Inc

Sign in to watch
Ticker
SNDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320162505
Phone
781-419-1400
Business address
730 THIRD AVENUE, 9TH FLOOR, NEW YORK, NY, 10017
  1. 4 Open-market sale Chief Executive Officer sold 7,412 shares at $20.62 ($152,835)
  2. 4 Open-market sale Chief Financial Officer sold 2,082 shares at $20.62 ($42,931)
  3. 4 Grant or award Director acquired 24,000 shares (grant or award)
  4. 4 Grant or award Director acquired 24,000 shares (grant or award)
  5. 4 Grant or award Head of R&D, CMO acquired 60,000 shares (grant or award)
  6. 4 Grant or award Director acquired 48,000 shares (grant or award)
  7. 4 Grant or award Director acquired 24,000 shares (grant or award)
  8. 4 Grant or award Director acquired 24,000 shares (grant or award)
  9. 4 Grant or award Director acquired 24,000 shares (grant or award)
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  13. 8-K Event Results of operations · Regulation FD disclosure
  14. 8-K Event Bylaws or fiscal year change
  15. 4 Gift Chief Financial Officer gave 1,224 shares (gift)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Other events
  19. 4 Planned sale Chief Executive Officer sold 157,307 shares at $16.41 ($2,582,021)
  20. 144 Insider Sale of Securities

Page 3 of 33 · 660 filings